Access to treatment worldwide: from talk to action at Durban

Abstract

More progress was made at this conference than ever before toward actually getting antiretrovirals and other high-priced medicines to poor countries. For example, a worldwide pricing study by Médecins San Frontières (Doctors Without Borders) found some modern antiretroviral combinations could be delivered as generics for about $200 per year per patient, assuming production in large quantities--and made recommendations for action now by national governments, and by public and private international agencies.